News
-
Zebrafish “avatars” can help decide who should receive radiotherapy treatment
17.12.2019
To date, there is no method for clearly determining whether radiotherapy will be an effective treatment for individual cancer patients. This is a significant problem as patients may be unnecessarily subjected to potentially severe side effects. A new assay offers a promising solution with rapid, personalized radiotherapy compatibility testing, using zebrafish as avatars.
[more...] -
Champalimaud scientist awarded €2 million to investigate how the brain 'learns on its feet'
10.12.2019
Megan Carey, the leader of the Neural Circuits and Behaviour lab at the Champalimaud Centre for the Unknown in Lisbon, Portugal, receives a Consolidator Grant from the European Research Council (ERC) to support her research for the next five years. It is the second five-year ERC grant awarded to Carey, following a €1.5 million Starting Grant in 2014.
[more...] -
ProjectAr take 01: Out of our seats and into the streets
30.10.2019
Ar | Respire Connosco launches ProjectAr – a new public event-series that aims to raise awareness for emerging societal issues while backing them up with science. The first event tackled climate change.
[more...] -
How many become one
15.10.2019
Peeping into the black box of AI to discover how collective behaviours emerge
[more...] -
Tumor resistance is promoted by anti-cancer protein
23.9.2019
New study reports the discovery of a mechanism that renders anti-cancer protein p53 ineffective against hypoxic cancer cells and in fact promotes their survival!
[more...]